Synchron's Brain Sensor for ALS Patients: A Revolution in 2-3 Years

Synchron's Stentrode BCI Technology

• 💡 Synchron's Stentrode BCI captures neural signals generated when a person thinks of moving.
• ⚡ These signals are translated into digital actions like scrolling, clicking, or moving a cursor.
• 🧠 The technology works by collecting motor intent signals, allowing users to control computers as if using a keyboard or mouse.

Less Invasive Implantation Procedure

• 🚀 Unlike competitors like Neuralink, Synchron's BCI does not require opening the skull (craniotomy).
• 🩺 The Stentrode is implanted via blood vessels in the brain, similar to cardiology procedures involving stents.
• ✅ This approach is significantly less invasive, with the procedure taking about an hour.

Expanding Accessibility Beyond ALS

• 🎯 The technology aims to help individuals with motor impairments in their upper limbs, including those affected by stroke or spinal cord injury.
• 📱 It restores independence by enabling users to operate devices like smartphones and computers, which they might otherwise be unable to use.
• 📊 An estimated 15 million people globally and 3 million in the US have motor impairments that could benefit.

Market Availability and Future Outlook

• 📈 Synchron has collaborated with the FDA for 13 years on this Class III medical device.
• ⏳ Commercial availability is anticipated within the next two to three years, not another decade.
• 🌟 This timeline offers significant hope for millions of people seeking to regain digital autonomy.